Wells Fargo & Company Omega Therapeutics, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 23,440 shares of OMGA stock, worth $26,252. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,440

Previous 31,703 26.06%

Holding current value

$26,252

Previous $115,000 58.26%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.86 - $3.2 $15,369 - $26,441	-8,263 Reduced 26.06%	23,440 $48,000
Q1 2024 May 10, 2024	BUY	$2.73 - $5.32 $32,694 - $63,712	11,976 Added 60.71%	31,703 $115,000
Q4 2023 Feb 09, 2024	BUY	$1.35 - $3.21 $1,937 - $4,606	1,435 Added 7.84%	19,727 $59,000
Q3 2023 Nov 13, 2023	BUY	$2.15 - $5.68 $17,522 - $46,292	8,150 Added 80.36%	18,292 $39,000
Q2 2023 Aug 15, 2023	BUY	$5.6 - $9.66 $56,106 - $96,783	10,019 Added 8145.53%	10,142 $56,000
Q1 2023 May 12, 2023	BUY	$4.81 - $10.95 $9 - $21	2 Added 1.65%	123 $0
Q4 2022 Feb 13, 2023	BUY	$4.22 - $7.05 $12 - $21	3 Added 2.54%	121 $0
Q3 2022 Nov 14, 2022	BUY	$3.63 - $6.65 $243 - $445	67 Added 131.37%	118 $1,000
Q2 2022 Aug 12, 2022	SELL	$2.01 - $7.19 $28,694 - $102,644	-14,276 Reduced 99.64%	51 $0
Q1 2022 May 16, 2022	BUY	$6.24 - $14.04 $6,932 - $15,598	1,111 Added 8.41%	14,327 $89,000
Q4 2021 Feb 14, 2022	BUY	$11.33 - $29.38 $149,272 - $387,081	13,175 Added 32134.15%	13,216 $150,000
Q3 2021 Nov 15, 2021	BUY	$16.0 - $22.51 $656 - $922	41 New	41 $1,000

Others Institutions Holding OMGA

# of Institutions

Shares Held

45.4M

Call Options Held

36.9K

Put Options Held

33.5K

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $53.6M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Omega Therapeutics, Inc. Transaction History